IMS Capital Management’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-11,472
Closed -$280K 144
2022
Q3
$280K Hold
11,472
0.19% 108
2022
Q2
$308K Hold
11,472
0.2% 104
2022
Q1
$448K Sell
11,472
-299
-3% -$11.6K 0.24% 93
2021
Q4
$540K Sell
11,771
-200
-2% -$9.55K 0.28% 77
2021
Q3
$567K Sell
11,971
-85
-0.7% -$3.97K 0.33% 71
2021
Q2
$559K Sell
12,056
-1,150
-9% -$52.1K 0.33% 72
2021
Q1
$579K Sell
13,206
-3,173
-19% -$144K 0.36% 68
2020
Q4
$672K Buy
16,379
+100
+0.6% +$3.9K 0.42% 57
2020
Q3
$607K Sell
16,279
-2,117
-12% -$78K 0.44% 62
2020
Q2
$633K Sell
18,396
-2,000
-10% -$62.1K 0.49% 60
2020
Q1
$571K Sell
20,396
-170
-0.8% -$5.66K 0.58% 56
2019
Q4
$714K Sell
20,566
-273
-1% -$9.23K 0.49% 53
2019
Q3
$672K Buy
20,839
+178
+0.9% +$6.08K 0.51% 51
2019
Q2
$708K Hold
20,661
0.53% 59
2019
Q1
$693K Buy
20,661
+1,613
+8% +$50.8K 0.57% 57
2018
Q4
$526K Buy
19,048
+15,828
+492% +$491K 0.49% 60
2018
Q3
$124K Sell
3,220
-13,939
-81% -$513K 0.08% 141
2018
Q2
$602K Buy
+17,159
New +$598K 0.38% 70

Other funds holding FFTY

IMS Capital Management's FFTY Position: Q4 2022 in Review

IMS Capital Management sold out of CapForce IBD 50 ETF (FFTY) in Q4 2022, closing a stake of 11,472 shares — an estimated $280K sold.

IMS Capital Management first reported a position in FFTY in Q2 2018 and held it in 18 quarters. The position peaked at $714K in Q4 2019. 49 funds tracked by Wall St. Rank hold FFTY as of Q4 2022.

  • IMS Capital Management reported no remaining CapForce IBD 50 ETF position as of Q4 2022 after selling out during the quarter.
  • IMS Capital Management sold 11,472 CapForce IBD 50 ETF shares in Q4 2022, an estimated $280K.
  • IMS Capital Management first reported a position in CapForce IBD 50 ETF in Q2 2018 and held it in 18 quarters.
  • IMS Capital Management's CapForce IBD 50 ETF position peaked at $714K in Q4 2019.
  • 49 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q4 2022.

Based on IMS Capital Management's 13F filing for Q4 2022, filed 22 Feb 2023.